NCT04190862View on ClinicalTrials.gov

E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas

PHASE1RecruitingINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

January 22, 2020

Primary Completion Date

September 30, 2025

Study Completion Date

June 30, 2032

Conditions
Anal Fistula
Interventions
DRUG

E-CEL UVEC

Injection of E-CEL UVEC

Trial Locations (1)

10065

RECRUITING

Weill Cornell Medical College - NewYork-Presbyterian Hospital, New York

Sponsors

Collaborators (1)

Angiocrine Bioscience
All Listed Sponsors
collaborator

Angiocrine Bioscience

INDUSTRY

lead

Weill Medical College of Cornell University

OTHER